Medical Condition News

RSS

Study calls for review of current treatment strategies, more research into stroke prevention

Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research into stroke prevention.

1 Oct 2011

Researchers identify protein-based blood biomarkers in patients treated with EPO

Biomarkers in the bloodstream could provide a rapid assessment of therapeutic intervention in ischemic stroke and allow patient stratification

1 Oct 2011

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

ViroPharma Incorporated today announced the license of worldwide rights from Intellect Neurosciences, Inc. to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.

1 Oct 2011

Blueberry powder may control triple negative breast cancer

In several studies recently conducted at the Beckman Research Institute at the City of Hope, Duarte, CA researchers found that feeding blueberry powder to mice significantly reduced the growth and spread of triple negative breast cancer cells, a very aggressive form of cancer.

1 Oct 2011

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced it has achieved 85 percent specificity and sensitivity with its EP-AD CSF Diagnostic Test.

1 Oct 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Merck, known as MSD outside of the United States and Canada, announced today that several new analyses from Phase III studies of VICTRELIS (boceprevir), the company's first-in-class, oral hepatitis C virus NS3/4A protease inhibitor will be presented at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases.

1 Oct 2011

CoreValve prosthesis shows promise against severe aortic stenosis

Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD, of University Hospitals (UH) Case Medical in Cleveland.

From Medtronic 1 Oct 2011

European and North American scientists to explore biology of heart failure

A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.

1 Oct 2011

Fred Hutchinson Cancer Research Center scientist wins NIH Director's Early Indpendence Award

Carissa Perez Olsen, Ph.D., a Weintraub Scholar in the Basic Sciences Division of Fred Hutchinson Cancer Research Center, is the recipient of the National Institutes of Health Director's Early Independence Award, announced today. She is among the first group of 10 junior U.S. investigators to receive the honor.

1 Oct 2011

The West Clinic forms new comprehensive breast center

The West Clinic, the Mid-South's premier cancer practice, is pleased to announce the formation of The West Clinic Comprehensive Breast Center, a multidisciplinary breast center, which will be the first center of its kind in the region.

1 Oct 2011

Poll: 21.4% of Americans believe vaccines can cause autism

More than one-quarter of Americans are concerned about the value and safety of vaccines and 21.4 percent believe vaccines can cause autism, according to the Thomson Reuters-NPR Health Poll.

1 Oct 2011

UCI study shows promise of metabolic therapy for autoimmune diseases

A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study.

1 Oct 2011

Novel binding assay can simplify search for potential SERT inhibitors

Many psychiatric conditions are caused by aberrant metabolism of the neurotransmitter serotonin. Researchers in the Department of Pharmacy at LMU have now developed a new screening method, which will facilitate the search for new drugs that modulate the biological activity of serotonin.

1 Oct 2011

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

1 Oct 2011

Baxter seeks European marketing authorization for HyQ to treat PI

Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.

From Baxter International Inc. 1 Oct 2011

Experts to discuss issues related to stroke at Canadian Stroke Congress

More than 900 of the top stroke researchers, clinicians and policy experts from across Canada and around the world are gathering at the Canadian Stroke Congress in Ottawa Oct. 3 and 4 to tackle issues related to stroke, a leading cause of death and disability in this country.

1 Oct 2011

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

ADVENTRX Pharmaceuticals, Inc. announced today that it held a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the complete response letter (CRL) it received in August from the FDA regarding the Company's New Drug Application (NDA) for Exelbine (vinorelbine injectable emulsion) for the treatment of non-small cell lung cancer.

1 Oct 2011

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

Kumar Sharma, MD, FAHA, professor of medicine at the University of California, San Diego School of Medicine and director of the Center for Renal Translational Medicine, has received a $5.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, to study kidney complications related to type 1 and type 2 diabetes.

1 Oct 2011

Researchers examine link between innate exercise capacity and survivability

Aerobic exercise capacity has proven to be a good indicator of health. A recent paper in Circulation Research whose authors include researchers from the Norwegian University of Science and Technology's KG Jebsen Center of Exercise in Medicine uses a rat model to show that innate exercise capacity can be linked to longevity.

1 Oct 2011

JenaValve's transapical TAVI system receives CE mark approval to treat aortic valve stenosis

JenaValve Technology GmbH, a German medical device company specializing in the development of transcatheter heart valve implantation systems, announced today that the Company has received CE mark approval for its transapical TAVI system of the second-generation. This system is used to treat severe aortic valve stenosis in elderly high-risk patients, especially in patients for whom conventional open-heart surgery is not an option.

1 Oct 2011

Medical Condition News

Study calls for review of current treatment strategies, more research into stroke prevention

Researchers identify protein-based blood biomarkers in patients treated with EPO

ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA

Blueberry powder may control triple negative breast cancer

Amorfix achieves 85% specificity and sensitivity with EP-AD CSF Diagnostic Test for AD

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

CoreValve prosthesis shows promise against severe aortic stenosis

European and North American scientists to explore biology of heart failure

Fred Hutchinson Cancer Research Center scientist wins NIH Director's Early Indpendence Award

The West Clinic forms new comprehensive breast center

Poll: 21.4% of Americans believe vaccines can cause autism

UCI study shows promise of metabolic therapy for autoimmune diseases

Novel binding assay can simplify search for potential SERT inhibitors

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Baxter seeks European marketing authorization for HyQ to treat PI

Experts to discuss issues related to stroke at Canadian Stroke Congress

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

Researchers examine link between innate exercise capacity and survivability

JenaValve's transapical TAVI system receives CE mark approval to treat aortic valve stenosis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News